Abstract
Coronary artery calcification (CAC), cardiac valve calcification (CVC) and left ventricular hypertrophy (LVH) are frequently observed in chronic kidney disease (CKD) patients. These abnormalities significantly affect morbidity and mortality. The aim of this study was to investigate the relationship between CAC, CVC and LVH in CKD patients. This study included 96 patients who were hospitalized and initiated hemodialysis between December 2011 and July 2014 at our five institutions. Multi-detector computed tomography for the quantification of CAC using the Agatston score and transthoracic echocardiography for assessing CVC and LVH were performed for all patients included in the study. We semi-quantitatively evaluated the severity of CVC as a valvular calcification score. We also assessed the presence of LVH in patients with CAC and/or CVC. Among the 96 patients, the prevalence of CAC was 81.3% and CVC was 65.0%. The severity of CAC was closely and significantly associated with that of CVC. The percentage of patients with LVH was the greatest in those with both severe CAC and CVC. CAC was significantly more severe in patients with concentric hypertrophy compared to those with normal geometry. At the initiation of hemodialysis, most CKD patients had CAC, CVC and LVH. In addition, cardiac calcification was significantly associated with LVH in these patients.
Similar content being viewed by others
References
Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112–S119
US Renal Data System (2013) USRDS 2013 annual data report. Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Panuccio V, Tripepi R, Tripepi G, Mallamaci F, Benedetto FA, Cataliotti A, Bellanuova I, Giacone G, Malatino LS, Zoccali C (2004) Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. Am J Kidney Dis 43:479–484
Raine AE (1994) Acquired aortic stenosis in dialysis patients. Nephron 68:159–168
Guerin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014–1021
Wang AY, London GM, Marchais SJ, Metivier F (2005) Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med 165:327–332
Kobayashi S, Oka M, Maesato K, Ikee R, Mano T, Hidekazu M, Ohtake T (2008) Coronary artery calcification, ADMA, and insulin resistance in CKD patients. Clin J Am Soc Nephrol 3:1289–1295
London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759–2767
Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE (1995) Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186–192
Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, Akkaya V, Erzengin F, Tepe S (2005) Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 20:760–767
Ventura JE, Tavella N, Romero C, Petraglia A, Báez A, Muñoz L (2002) Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 17:1795–1801
Elmariah S, Delaney JA, Bluemke DA, Budoff MJ, O’Brien KD, Fuster V, Kronmal RA, Halperin JL (2012) Associations of LV hypertrophy with prevalent and incident valve calcification: multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging 5:781–788
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458
Kim IY, Kim MJ, Lee DW, Lee SB, Shin MJ, Rhee H, Yang BY, Song SH, Seong EY, Kwak IS (2015) Cardiac valve calcification is associated with presence and severity of coronary artery disease in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol 19:1090–1097
Ix JH, Shlipak MG, Katz R, Budoff MJ, Shavelle DM, Probstfield JL, Takasu J, Detrano R, O’Brien KD (2007) Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 50:412–420
Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE (2004) Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44:1024–1030
Choi MJ, Kim JK, Kim SG, Yoon JW, Koo JR, Kim HJ, Song YR (2013) Left atrial volume index is a predictor of silent myocardial ischemia in high-risk patients with end-stage renal disease. Int J Cardiovasc Imaging 29:1433–1439
Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG (2012) Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23:1725–1734
Temmar M, Liabeuf S, Renard C, Czernichow S, Esper NE, Shahapuni I, Presne C, Makdassi R, Andrejak M, Tribouilloy C, Galan P, Safar ME, Choukroun G, Massy Z (2010) Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 28:163–169
Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68:1815–1824
Di Iorio B, Nargi O, Cucciniello E, Bellizzi V, Torraca S, Russo D, Bellasi A, INDEPENDENT study investigators (2011) Coronary artery calcification progression is associated with arterial stiffness and cardiac repolarization deterioration in hemodialysis patients. Kidney Blood Press Res 34:180–187
Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P (2010) Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303:1610–1666
Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM (2007) Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71:438–441
Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O’Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA (2008) Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358:1336–1345
Paloian NJ, Giachelli CM (2014) A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol 307:F891–900
Raggi P, Bellasi A, Gamboa C, Ferramosca E, Ratti C, Block GA, Muntner P (2011) All-cause mortality in hemodialysis patients with heart valve calcification. Clin J Am Soc Nephrol 6:1990–1995
Bellasi A, Ferramosca E, Ratti C, Block G, Raggi P (2012) Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients. J Nephrol 25:211–218
Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE (2001) Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927–1936
Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394–401
Leskinen Y, Paana T, Saha H, Groundstroem K, Lehtimäki T, Kilpinen S, Huhtala H, Airaksinen J (2009) Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis 18:429–438
Benjamin EJ, Plehn JF, D’Agostino RB, Belanger AJ, Comai K, Fuller DL, Wolf PA, Levy D (1992) Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med 327:374–379
Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341:142–147
Barasch E, Gottdiener JS, Marino Larsen EK, Chaves PH, Newman AB (2006) Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study). Am J Cardiol 97:1281–1286
Sharma R, Pellerin D, Gaze DC, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ (2007) Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease. Atherosclerosis 191:348–354
Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, Leip EP, O’donnell CJ, D’Agostino RB Sr, Benjamin EJ (2006) Cross-sectional association of kidney function with valvular and annular calcification: the Framingham Heart Study. J Am Soc Nephrol 17:521–527
Fox CS, Vasan RS, Parise H, Levy D, O’Donnell CJ, D’Agostino RB, Benjamin EJ (2003) Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation 107:1492–1496
Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G (2004) The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 19:1829–1834
Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286–290
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024–2031
Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C (2015) Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med 5:254–66
Kono K, Fujii H, Nakai K, Goto S, Shite J, Hirata K, Fukagawa M, Nishi S (2012) Composition and plaque patterns of coronary culprit lesions and clinical characteristics of patients with chronic kidney disease. Kidney Int 82:344–351
Sato A, Aonuma K (2015) Role of cardiac multidetector computed tomography beyond coronary angiography. Circ J 79:712–720
Raggi P, Bellasi A, Ferramosca E, Block GA, Muntner P (2007) Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension 49:1278–1284
Lemos MM, Jancikic AD, Sanches FM, Christofalo DM, Ajzen SA, Miname MH, Santos RD, Fachini FC, Carvalho AB, Draibe SA, Canziani ME (2007) Pulse wave velocity—a useful tool for cardiovascular surveillance in pre-dialysis patients. Nephrol Dial Transplant 22:3527–3532
Takayama Y, Yasuda Y, Suzuki S, Shibata Y, Tatami Y, Shibata K, Niwa M, Sawai A, Morimoto R, Kato S, Ishii H, Maruyama S, Murohara T (2016) Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients. Heart Vessels 31:1030–1037
Ueki Y, Miura T, Minamisawa M, Abe N, Nishimura H, Hashizume N, Mochidome T, Harada M, Shimizu K, Oguchi Y, Yoshie K, Shoin W, Ebisawa S, Motoki H, Koyama J, Ikeda U (2016) The usefulness of brachial–ankle pulse wave velocity in predicting long-term cardiovascular events in younger patients. Heart Vessels. doi:10.1007/s00380-016-0919-6
Caliskan Y, Demirturk M, Ozkok A, Yelken B, Sakaci T, Oflaz H, Unsal A, Yildiz A (2010) Coronary artery calcification and coronary flow velocity in haemodialysis patients. Nephrol Dial Transplant 25:2685–2690
Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, Torricelli F, Camici PG (2006) Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:1043–1048
Camici PG, Olivotto I, Rimoldi OE (2012) The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol 52:857–864
Bae EH, Lim SY, Cho KH, Choi JS, Kim CS, Park JW, Ma SK, Jeong MH, Kim SW (2012) GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 59:795–802
Acknowledgements
This study was partly presented at the annual meeting of American Society of Nephrology Congress, 2013.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
This study was partly supported by Bayer Pharmaceutical Co.
Rights and permissions
About this article
Cite this article
Kitamura, K., Fujii, H., Nakai, K. et al. Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation. Heart Vessels 32, 1109–1116 (2017). https://doi.org/10.1007/s00380-017-0969-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-017-0969-4